Transcription factor 21 (TCF21), a basic-helix-loop-helix transcription factor that contributes to the risk of coronary heart disease, blocks the MYOCD-SRF pathway via direct TCF21-MYOCD interaction and results in a less differentiated phenotype (Nagao et al. 2020). Here, MYOCD is linked to coronary artery disorder.